Given observed associations of increasing levels of adiposity with poorer breast cancer survival, we examined relationships between breast tumor IHC expression of adipokine biomarkers (LEP, LEPR, ADIPOQ, ADIPOR1, ADIPOR2) with tumor clinicopathological features that are associated with poorer prognosis. This evidence concerns the gene LEP and breast cancer.